Tamron Astra Bio-Chemicals Profile
Key Indicators
- Authorised Capital ₹ 6.20 Cr
as on 27-06-2024
- Paid Up Capital ₹ 6.20 Cr
as on 27-06-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.00 Cr
as on 27-06-2024
- Revenue -28.37%
(FY 2021)
- Profit 9.31%
(FY 2021)
- Ebitda 102.80%
(FY 2021)
- Net Worth -0.43%
(FY 2021)
- Total Assets -13.00%
(FY 2021)
About Tamron Astra Bio-Chemicals
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 6.20 Cr and a paid-up capital of Rs 6.20 Cr.
The company currently has active open charges totaling ₹2.00 Cr.
Ramesh Joshi, Amit Kumar, and Emad Aiasah serve as directors at the Company.
- CIN/LLPIN
U24110KA2016PTC085546
- Company No.
085546
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 2016
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tamron Astra Bio-Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Joshi  | Additional Director | 17-Feb-2021 | Current |
| Amit Kumar | Additional Director | 27-Apr-2019 | Current |
Emad Aiasah  | Director | 13-Mar-2019 | Current |
Financial Performance of Tamron Astra Bio-Chemicals.
Tamron Astra Bio-Chemicals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 28.37% decrease. The company also saw a slight improvement in profitability, with a 9.31% increase in profit. The company's net worth dipped by a decrease of 0.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tamron Astra Bio-Chemicals?
In 2021, Tamron Astra Bio-Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 07 Oct 2016 | ₹2.00 Cr | Open |
How Many Employees Work at Tamron Astra Bio-Chemicals?
Tamron Astra Bio-Chemicals has a workforce of 39 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tamron Astra Bio-Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tamron Astra Bio-Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
